Randomized Controlled Trial
Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial.
BMJ. 2016 Jun 15; 353: i2868.
Randomized Controlled Trial
Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and...
J. Am. Coll. Cardiol. 2014 May 27;63(20):2141-7.
Randomized Controlled Trial
Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.
Am. Heart J. 2010 Mar 1; 159 (3): 331-9.